{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:47:41Z","timestamp":1792226861354,"version":"4.4.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T00:00:00Z","timestamp":1643155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T00:00:00Z","timestamp":1643155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","award":["2019-I2M-2\u2013003"],"award-info":[{"award-number":["2019-I2M-2\u2013003"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["91857118, 81773537, 82030102"],"award-info":[{"award-number":["91857118, 81773537, 82030102"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s00125-021-05645-7","type":"journal-article","created":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T15:07:28Z","timestamp":1643209648000},"page":"695-704","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Using genetics to assess the association of commonly used antihypertensive drugs with diabetes, glycaemic traits and lipids: a trans-ancestry Mendelian randomisation study"],"prefix":"10.1007","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1564-0057","authenticated-orcid":false,"given":"Jie V.","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangchao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Mary","family":"Schooling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongfeng","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4088-2338","authenticated-orcid":false,"given":"Xiangfeng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,26]]},"reference":[{"issue":"9153","key":"5645_CR1","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/s0140-6736(98)05012-0","volume":"353","author":"L Hansson","year":"1999","unstructured":"Hansson L, Lindholm LH, Niskanen L et al (1999) Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the captopril prevention project (CAPPP) randomised trial. Lancet 353(9153):611\u2013616. https:\/\/doi.org\/10.1016\/s0140-6736(98)05012-0","journal-title":"Lancet"},{"issue":"3","key":"5645_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/s0828-282x(06)70902-3","volume":"22","author":"DF Blackburn","year":"2006","unstructured":"Blackburn DF, Wilson TW (2006) Antihypertensive medications and blood sugar: theories and implications. Can J Cardiol 22(3):229\u2013233. https:\/\/doi.org\/10.1016\/s0828-282x(06)70902-3","journal-title":"Can J Cardiol"},{"key":"5645_CR3","unstructured":"NICE (2019) NICE guideline [NG136]. Available from www.nice.org.uk\/guidance\/ng136\/chapter\/Recommendations#choosing-antihypertensive-drug-treatment-for-people-with-or-without-type-2-diabetes"},{"issue":"15","key":"5645_CR4","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1056\/NEJMoa065061","volume":"355","author":"J Bosch","year":"2006","unstructured":"DREAM Trial Investigators, Bosch J, Yusuf S et al (2006) Effect of ramipril on the incidence of diabetes. N Engl J Med 355(15):1551\u20131562. https:\/\/doi.org\/10.1056\/NEJMoa065061","journal-title":"N Engl J Med"},{"issue":"36","key":"5645_CR5","doi-asserted-by":"publisher","first-page":"e1495","DOI":"10.1097\/MD.0000000000001495","volume":"94","author":"YS Liou","year":"2015","unstructured":"Liou YS, Chen HY, Tien L, Gu YS, Jong GP (2015) Antihypertensive drug use and new-onset diabetes in female patients with coronary artery disease: a population-based longitudinal cohort study. Medicine (Baltimore) 94(36):e1495. https:\/\/doi.org\/10.1097\/MD.0000000000001495","journal-title":"Medicine (Baltimore)"},{"issue":"13","key":"5645_CR6","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1056\/NEJM200003303421301","volume":"342","author":"TW Gress","year":"2000","unstructured":"Gress TW, Nieto FJ, Shahar E, Wofford MR, Brancati FL (2000) Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis risk in communities study. N Engl J Med 342(13):905\u2013912. https:\/\/doi.org\/10.1056\/NEJM200003303421301","journal-title":"N Engl J Med"},{"key":"5645_CR7","doi-asserted-by":"publisher","unstructured":"Lee WG, Murphy R, McCall JL et al (2017) Nadolol reduces insulin sensitivity in liver cirrhosis: a randomized double-blind crossover trial. Diabetes Metab Res Rev 33(3). https:\/\/doi.org\/10.1002\/dmrr.2859","DOI":"10.1002\/dmrr.2859"},{"issue":"11","key":"5645_CR8","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/jhh.2010.3","volume":"24","author":"N Racine","year":"2010","unstructured":"Racine N, Hamet P, Sampalis JS, Longo N, Bastien N (2010) A 52-week prospective, cohort study of the effects of losartan with or without hydrochlorothiazide (HCTZ) in hypertensive patients with metabolic syndrome. J Hum Hypertens 24(11):739\u2013748. https:\/\/doi.org\/10.1038\/jhh.2010.3","journal-title":"J Hum Hypertens"},{"issue":"2","key":"5645_CR9","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2337\/dc07-1452","volume":"31","author":"HR Black","year":"2008","unstructured":"Black HR, Davis B, Barzilay J et al (2008) Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). Diabetes Care 31(2):353\u2013360. https:\/\/doi.org\/10.2337\/dc07-1452","journal-title":"Diabetes Care"},{"issue":"2","key":"5645_CR10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/s0168-8227(99)00149-7","volume":"48","author":"R Rachmani","year":"2000","unstructured":"Rachmani R, Lidar M, Brosh D, Levi Z, Ravid M (2000) Oxidation of low-density lipoprotein in normotensive type 2 diabetic patients. Comparative effects of enalapril versus nifedipine: a randomized cross-over over study. Diabetes Res Clin Pract 48(2):139\u2013145. https:\/\/doi.org\/10.1016\/s0168-8227(99)00149-7","journal-title":"Diabetes Res Clin Pract"},{"issue":"14","key":"5645_CR11","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/s0002-9149(99)80703-6","volume":"75","author":"KS Woo","year":"1995","unstructured":"Woo KS, Norris RM, Nicholls G (1995) Racial difference in incidence of cough with angiotensin-converting enzyme inhibitors (a tale of two cities). Am J Cardiol 75(14):967\u2013968. https:\/\/doi.org\/10.1016\/s0002-9149(99)80703-6","journal-title":"Am J Cardiol"},{"key":"5645_CR12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/nyas.12098","volume":"1281","author":"RC Ma","year":"2013","unstructured":"Ma RC, Chan JC (2013) Type 2 diabetes in east Asians: similarities and differences with populations in Europe and the United States. Ann N Y Acad Sci 1281:64\u201391. https:\/\/doi.org\/10.1111\/nyas.12098","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"5645_CR13","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1093\/eurheartj\/ehx462","volume":"39","author":"BA Ference","year":"2018","unstructured":"Ference BA (2018) How to use Mendelian randomization to anticipate the results of randomized trials. Eur Heart J 39(5):360\u2013362. https:\/\/doi.org\/10.1093\/eurheartj\/ehx462","journal-title":"Eur Heart J"},{"key":"5645_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.12688\/wellcomeopenres.16544.2","volume":"6","author":"D Gill","year":"2021","unstructured":"Gill D, Georgakis MK, Walker VM et al (2021) Mendelian randomization for studying the effects of perturbing drug targets. Wellcome Open Res 6:16. https:\/\/doi.org\/10.12688\/wellcomeopenres.16544.2","journal-title":"Wellcome Open Res"},{"issue":"6","key":"5645_CR15","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1161\/ATVBAHA.120.315482","volume":"41","author":"MG Levin","year":"2021","unstructured":"Levin MG, Klarin D, Walker VM et al (2021) Association between genetic variation in blood pressure and increased lifetime risk of peripheral artery disease. Arterioscler Thromb Vasc Biol 41(6):2027\u20132034. https:\/\/doi.org\/10.1161\/ATVBAHA.120.315482","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"5645_CR16","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1161\/CIRCULATIONAHA.118.038814","volume":"140","author":"D Gill","year":"2019","unstructured":"Gill D, Georgakis MK, Koskeridis F et al (2019) Use of genetic variants related to antihypertensive drugs to inform on efficacy and side effects. Circulation 140(4):270\u2013279. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.038814","journal-title":"Circulation"},{"issue":"4","key":"5645_CR17","doi-asserted-by":"publisher","first-page":"e353","DOI":"10.1212\/WNL.0000000000009814","volume":"95","author":"MK Georgakis","year":"2020","unstructured":"Georgakis MK, Gill D, Webb AJS et al (2020) Genetically determined blood pressure, antihypertensive drug classes, and risk of stroke subtypes. Neurology 95(4):e353\u2013e361. https:\/\/doi.org\/10.1212\/WNL.0000000000009814","journal-title":"Neurology"},{"issue":"1","key":"5645_CR18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12916-021-01951-4","volume":"19","author":"JV Zhao","year":"2021","unstructured":"Zhao JV, Schooling CM (2021) Using Mendelian randomization study to assess the renal effects of antihypertensive drugs. BMC Med 19(1):79. https:\/\/doi.org\/10.1186\/s12916-021-01951-4","journal-title":"BMC Med"},{"issue":"4","key":"5645_CR19","doi-asserted-by":"publisher","first-page":"835","DOI":"10.2337\/dc19-1973","volume":"43","author":"M Pigeyre","year":"2020","unstructured":"Pigeyre M, Sjaarda J, Chong M et al (2020) ACE and type 2 diabetes risk: a Mendelian randomization study. Diabetes Care 43(4):835\u2013842. https:\/\/doi.org\/10.2337\/dc19-1973","journal-title":"Diabetes Care"},{"issue":"2","key":"5645_CR20","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.ajhg.2014.12.021","volume":"96","author":"H Aschard","year":"2015","unstructured":"Aschard H, Vilhjalmsson BJ, Joshi AD, Price AL, Kraft P (2015) Adjusting for heritable covariates can bias effect estimates in genome-wide association studies. Am J Hum Genet 96(2):329\u2013339. https:\/\/doi.org\/10.1016\/j.ajhg.2014.12.021","journal-title":"Am J Hum Genet"},{"issue":"3","key":"5645_CR21","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41588-018-0047-6","volume":"50","author":"M Kanai","year":"2018","unstructured":"Kanai M, Akiyama M, Takahashi A et al (2018) Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases. Nat Genet 50(3):390\u2013400. https:\/\/doi.org\/10.1038\/s41588-018-0047-6","journal-title":"Nat Genet"},{"issue":"3","key":"5645_CR22","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1093\/hmg\/ddu478","volume":"24","author":"X Lu","year":"2015","unstructured":"Lu X, Wang L, Lin X et al (2015) Genome-wide association study in Chinese identifies novel loci for blood pressure and hypertension. Hum Mol Genet 24(3):865\u2013874. https:\/\/doi.org\/10.1093\/hmg\/ddu478","journal-title":"Hum Mol Genet"},{"issue":"1","key":"5645_CR23","doi-asserted-by":"publisher","first-page":"5052","DOI":"10.1038\/s41467-018-07345-0","volume":"9","author":"F Takeuchi","year":"2018","unstructured":"Takeuchi F, Akiyama M, Matoba N et al (2018) Interethnic analyses of blood pressure loci in populations of east Asian and European descent. Nat Commun 9(1):5052. https:\/\/doi.org\/10.1038\/s41467-018-07345-0","journal-title":"Nat Commun"},{"issue":"11","key":"5645_CR24","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1038\/s41588-018-0241-6","volume":"50","author":"A Mahajan","year":"2018","unstructured":"Mahajan A, Taliun D, Thurner M et al (2018) Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps. Nat Genet 50(11):1505\u20131513. https:\/\/doi.org\/10.1038\/s41588-018-0241-6","journal-title":"Nat Genet"},{"issue":"7811","key":"5645_CR25","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41586-020-2263-3","volume":"582","author":"CN Spracklen","year":"2020","unstructured":"Spracklen CN, Horikoshi M, Kim YJ et al (2020) Identification of type 2 diabetes loci in 433,540 east Asian individuals. Nature 582(7811):240\u2013245. https:\/\/doi.org\/10.1038\/s41586-020-2263-3","journal-title":"Nature"},{"issue":"3","key":"5645_CR26","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N et al (2015) UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med 12(3):e1001779. https:\/\/doi.org\/10.1371\/journal.pmed.1001779","journal-title":"PLoS Med"},{"issue":"11","key":"5645_CR27","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/ng.2797","volume":"45","author":"CJ Willer","year":"2013","unstructured":"Willer CJ, Schmidt EM, Sengupta S et al (2013) Discovery and refinement of loci associated with lipid levels. Nat Genet 45(11):1274\u20131283. https:\/\/doi.org\/10.1038\/ng.2797","journal-title":"Nat Genet"},{"key":"5645_CR28","unstructured":"UK Biobank (2018) Nightingale Health and UK Biobank announces major initiative to analyse half a million blood samples to facilitate global medical research. Available from www.ukbiobank.ac.uk\/learn-more-about-uk-biobank\/news\/nightingale-health-and-uk-biobank-announces-major-initiative-to-analyse-half-a-million-blood-samples-to-facilitate-global-medical-research"},{"issue":"1","key":"5645_CR29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1161\/CIRCGENETICS.115.001096","volume":"9","author":"X Lu","year":"2016","unstructured":"Lu X, Huang J, Mo Z et al (2016) Genetic susceptibility to lipid levels and lipid change over time and risk of incident hyperlipidemia in Chinese populations. Circ Cardiovasc Genet 9(1):37\u201344. https:\/\/doi.org\/10.1161\/CIRCGENETICS.115.001096","journal-title":"Circ Cardiovasc Genet"},{"issue":"3","key":"5645_CR30","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1161\/CIRCRESAHA.117.312086","volume":"122","author":"P van der Harst","year":"2018","unstructured":"van der Harst P, Verweij N (2018) Identification of 64 novel genetic loci provides an expanded view on the genetic architecture of coronary artery disease. Circ Res 122(3):433\u2013443. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.312086","journal-title":"Circ Res"},{"issue":"7","key":"5645_CR31","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41588-020-0640-3","volume":"52","author":"K Ishigaki","year":"2020","unstructured":"Ishigaki K, Akiyama M, Kanai M et al (2020) Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases. Nat Genet 52(7):669\u2013679. https:\/\/doi.org\/10.1038\/s41588-020-0640-3","journal-title":"Nat Genet"},{"issue":"12","key":"5645_CR32","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1038\/ng.3978","volume":"49","author":"X Lu","year":"2017","unstructured":"Lu X, Peloso GM, Liu DJ et al (2017) Exome chip meta-analysis identifies novel loci and east Asian-specific coding variants that contribute to lipid levels and coronary artery disease. Nat Genet 49(12):1722\u20131730. https:\/\/doi.org\/10.1038\/ng.3978","journal-title":"Nat Genet"},{"issue":"3","key":"5645_CR33","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1093\/ije\/dyu005","volume":"43","author":"S Burgess","year":"2014","unstructured":"Burgess S (2014) Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome. Int J Epidemiol 43(3):922\u2013929. https:\/\/doi.org\/10.1093\/ije\/dyu005","journal-title":"Int J Epidemiol"},{"issue":"4","key":"5645_CR34","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1093\/ije\/dyt110","volume":"42","author":"G Freeman","year":"2013","unstructured":"Freeman G, Cowling BJ, Schooling CM (2013) Power and sample size calculations for Mendelian randomization studies using one genetic instrument. Int J Epidemiol 42(4):1157\u20131163. https:\/\/doi.org\/10.1093\/ije\/dyt110","journal-title":"Int J Epidemiol"},{"issue":"11","key":"5645_CR35","doi-asserted-by":"publisher","first-page":"e1007081","DOI":"10.1371\/journal.pgen.1007081","volume":"13","author":"G Hemani","year":"2017","unstructured":"Hemani G, Tilling K, Smith GD (2017) Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet 13(11):e1007081. https:\/\/doi.org\/10.1371\/journal.pgen.1007081","journal-title":"PLoS Genet"},{"issue":"4","key":"5645_CR36","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC, Burgess S (2016) Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol 40(4):304\u2013314. https:\/\/doi.org\/10.1002\/gepi.21965","journal-title":"Genet Epidemiol"},{"issue":"5","key":"5645_CR37","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen CY, Neale B, Do R (2018) Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet 50(5):693\u2013698. https:\/\/doi.org\/10.1038\/s41588-018-0099-7","journal-title":"Nat Genet"},{"issue":"12","key":"5645_CR38","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/S0895-4356(98)00131-0","volume":"51","author":"AP Verhagen","year":"1998","unstructured":"Verhagen AP, de Vet HC, de Bie RA et al (1998) The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol 51(12):1235\u20131241. https:\/\/doi.org\/10.1016\/S0895-4356(98)00131-0","journal-title":"J Clin Epidemiol"},{"issue":"8","key":"5645_CR39","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.amjcard.2007.05.057","volume":"100","author":"S Bangalore","year":"2007","unstructured":"Bangalore S, Parkar S, Grossman E, Messerli FH (2007) A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus. Am J Cardiol 100(8):1254\u20131262. https:\/\/doi.org\/10.1016\/j.amjcard.2007.05.057","journal-title":"Am J Cardiol"},{"issue":"2","key":"5645_CR40","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1136\/ebm.13.2.50","volume":"13","author":"S Belknap","year":"2008","unstructured":"Belknap S (2008) Review: \u03b2-blockers for hypertension increase risk of new onset diabetes. Evid Based Med 13(2):50. https:\/\/doi.org\/10.1136\/ebm.13.2.50","journal-title":"Evid Based Med"},{"issue":"2","key":"5645_CR41","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/s0021-9150(97)00278-5","volume":"137","author":"S Boquist","year":"1998","unstructured":"Boquist S, Ruotolo G, Hellenius ML, Danell-Toverud K, Karpe F, Hamsten A (1998) Effects of a cardioselective \u03b2-blocker on postprandial triglyceride-rich lipoproteins, low density lipoprotein particle size and glucose-insulin homeostasis in middle-aged men with modestly increased cardiovascular risk. Atherosclerosis 137(2):391\u2013400. https:\/\/doi.org\/10.1016\/s0021-9150(97)00278-5","journal-title":"Atherosclerosis"},{"issue":"4","key":"5645_CR42","doi-asserted-by":"publisher","first-page":"2B","DOI":"10.1016\/0002-9149(89)90931-4","volume":"63","author":"M Moser","year":"1989","unstructured":"Moser M (1989) Relative efficacy of, and some adverse reactions to, different antihypertensive regimens. Am J Cardiol 63(4):2B\u20137B. https:\/\/doi.org\/10.1016\/0002-9149(89)90931-4","journal-title":"Am J Cardiol"},{"issue":"11","key":"5645_CR43","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1038\/ijo.2010.284","volume":"35","author":"P Lee","year":"2011","unstructured":"Lee P, Kengne AP, Greenfield JR, Day RO, Chalmers J, Ho KK (2011) Metabolic sequelae of \u03b2-blocker therapy: weighing in on the obesity epidemic? Int J Obes 35(11):1395\u20131403. https:\/\/doi.org\/10.1038\/ijo.2010.284","journal-title":"Int J Obes"},{"issue":"5","key":"5645_CR44","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1055\/s-0032-1329988","volume":"45","author":"AB Segarra","year":"2013","unstructured":"Segarra AB, Prieto I, Villarejo AB et al (2013) Effects of antihypertensive drugs on angiotensinase activities in the testis of spontaneously hypertensive rats. Horm Metab Res 45(5):344\u2013348. https:\/\/doi.org\/10.1055\/s-0032-1329988","journal-title":"Horm Metab Res"},{"issue":"2","key":"5645_CR45","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41591-020-0751-5","volume":"26","author":"KS Ruth","year":"2020","unstructured":"Ruth KS, Day FR, Tyrrell J et al (2020) Using human genetics to understand the disease impacts of testosterone in men and women. Nat Med 26(2):252\u2013258. https:\/\/doi.org\/10.1038\/s41591-020-0751-5","journal-title":"Nat Med"},{"issue":"4","key":"5645_CR46","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1291\/hypres.21.279","volume":"21","author":"H Koshida","year":"1998","unstructured":"Koshida H, Takeda R, Miyamori I (1998) Lisinopril decreases plasma free testosterone in male hypertensive patients and increases sex hormone binding globulin in female hypertensive patients. Hypertens Res 21(4):279\u2013282. https:\/\/doi.org\/10.1291\/hypres.21.279","journal-title":"Hypertens Res"},{"key":"5645_CR47","doi-asserted-by":"publisher","first-page":"k601","DOI":"10.1136\/bmj.k601","volume":"362","author":"NM Davies","year":"2018","unstructured":"Davies NM, Holmes MV, Davey Smith G (2018) Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ 362:k601. https:\/\/doi.org\/10.1136\/bmj.k601","journal-title":"BMJ"},{"issue":"7","key":"5645_CR48","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/gepi.21998","volume":"40","author":"S Burgess","year":"2016","unstructured":"Burgess S, Davies NM, Thompson SG (2016) Bias due to participant overlap in two-sample Mendelian randomization. Genet Epidemiol 40(7):597\u2013608. https:\/\/doi.org\/10.1002\/gepi.21998","journal-title":"Genet Epidemiol"},{"key":"5645_CR49","doi-asserted-by":"publisher","unstructured":"Minelli C, Del Greco MF, van der Plaat DA, Bowden J, Sheehan NA, Thompson J (2021) The use of two-sample methods for Mendelian randomization analyses on single large datasets. Int J Epidemiol 50(5):1651\u20131659. https:\/\/doi.org\/10.1093\/ije\/dyab084","DOI":"10.1093\/ije\/dyab084"},{"issue":"8","key":"5645_CR50","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/Sim.3034","volume":"27","author":"DA Lawlor","year":"2008","unstructured":"Lawlor DA, Harbord RM, Sterne JAC, Timpson N, Davey-Smith G (2008) Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 27(8):1133\u20131163. https:\/\/doi.org\/10.1002\/Sim.3034","journal-title":"Stat Med"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-021-05645-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-021-05645-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-021-05645-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T01:03:17Z","timestamp":1674694997000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-021-05645-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,26]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["5645"],"URL":"https:\/\/doi.org\/10.1007\/s00125-021-05645-7","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,26]]},"assertion":[{"value":"16 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}